The FDA approved the first drug to protect all infants against respiratory syncytial virus, or RSV, the leading cause of hospitalization of infants in the U.S.

The FDA approved the first drug to protect all infants against respiratory syncytial virus, or RSV, the leading cause of hospitalization of infants in the U.S. https://ift.tt/NmieU6O